Elevance Health Other Long-Term Assets 2010-2025 | ELV
Elevance Health other long-term assets from 2010 to 2025. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- Elevance Health other long-term assets for the quarter ending March 31, 2025 were $2.392B, a 6.55% increase year-over-year.
- Elevance Health other long-term assets for 2024 were $2.14B, a 8.8% increase from 2023.
- Elevance Health other long-term assets for 2023 were $1.967B, a 16.6% increase from 2022.
- Elevance Health other long-term assets for 2022 were $1.687B, a 1.86% decline from 2021.
| Elevance Health Annual Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024 | $2,140 |
| 2023 | $1,967 |
| 2022 | $1,687 |
| 2021 | $1,719 |
| 2020 | $1,438 |
| 2019 | $1,350 |
| 2018 | $758 |
| 2017 | $565 |
| 2016 | $468 |
| 2015 | $485 |
| 2014 | $512 |
| 2013 | $645 |
| 2012 | $486 |
| 2011 | $478 |
| 2010 | $488 |
| 2009 | $393 |
| Elevance Health Quarterly Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $2,392 |
| 2024-12-31 | $2,140 |
| 2024-09-30 | $2,603 |
| 2024-06-30 | $2,196 |
| 2024-03-31 | $2,245 |
| 2023-12-31 | $1,967 |
| 2023-09-30 | $2,329 |
| 2023-06-30 | $2,133 |
| 2023-03-31 | $1,857 |
| 2022-12-31 | $1,687 |
| 2022-09-30 | $2,171 |
| 2022-06-30 | $2,002 |
| 2022-03-31 | $1,803 |
| 2021-12-31 | $1,719 |
| 2021-09-30 | $1,804 |
| 2021-06-30 | $1,689 |
| 2021-03-31 | $1,563 |
| 2020-12-31 | $1,438 |
| 2020-09-30 | $1,849 |
| 2020-06-30 | $1,950 |
| 2020-03-31 | $1,833 |
| 2019-12-31 | $1,350 |
| 2019-09-30 | $1,667 |
| 2019-06-30 | $1,608 |
| 2019-03-31 | $1,453 |
| 2018-12-31 | $758 |
| 2018-09-30 | $1,074 |
| 2018-06-30 | $950 |
| 2018-03-31 | $832 |
| 2017-12-31 | $565 |
| 2017-09-30 | $851 |
| 2017-06-30 | $778 |
| 2017-03-31 | $641 |
| 2016-12-31 | $468 |
| 2016-09-30 | $1,169 |
| 2016-06-30 | $862 |
| 2016-03-31 | $610 |
| 2015-12-31 | $485 |
| 2015-09-30 | $661 |
| 2015-06-30 | $864 |
| 2015-03-31 | $746 |
| 2014-12-31 | $512 |
| 2014-09-30 | $665 |
| 2014-06-30 | $676 |
| 2014-03-31 | $636 |
| 2013-12-31 | $645 |
| 2013-09-30 | $456 |
| 2013-06-30 | $465 |
| 2013-03-31 | $483 |
| 2012-12-31 | $486 |
| 2012-09-30 | $452 |
| 2012-06-30 | $459 |
| 2012-03-31 | $446 |
| 2011-12-31 | $478 |
| 2011-09-30 | $539 |
| 2011-06-30 | $557 |
| 2011-03-31 | $542 |
| 2010-12-31 | $488 |
| 2010-09-30 | $455 |
| 2010-06-30 | $439 |
| 2010-03-31 | $413 |
| 2009-12-31 | $393 |
| 2009-09-30 | $376 |
| 2009-06-30 | $365 |
| 2009-03-31 | $386 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $91.117B | $177.011B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.350B | 26.32 |
| CVS Health (CVS) | United States | $79.102B | 9.83 |
| Cencora (COR) | United States | $56.251B | 19.57 |
| DiDi Global (DIDIY) | China | $21.979B | 33.36 |
| Natera (NTRA) | United States | $20.836B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.822B | 13.57 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.604B | 0.00 |
| CochLear (CHEOY) | Australia | $11.282B | 0.00 |
| Revvity (RVTY) | United States | $10.993B | 18.92 |
| ICON (ICLR) | Ireland | $10.630B | 9.88 |
| Viatris (VTRS) | United States | $10.375B | 3.56 |
| Doximity (DOCS) | United States | $9.813B | 45.70 |
| Avantor (AVTR) | United States | $9.138B | 13.28 |
| Medpace Holdings (MEDP) | United States | $8.785B | 23.33 |
| HealthEquity (HQY) | United States | $8.497B | 41.80 |
| Sonic Healthcare (SKHHY) | Australia | $8.220B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.924B | 13.57 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.257B | 39.40 |
| Bausch + Lomb (BLCO) | Canada | $4.156B | 24.50 |
| Sotera Health (SHC) | United States | $3.633B | 20.65 |
| Alignment Healthcare (ALHC) | United States | $3.122B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.068B | 39.90 |
| Concentras Parent (CON) | United States | $2.912B | 16.83 |
| Organon (OGN) | United States | $2.350B | 2.50 |
| Ardent Health Partners (ARDT) | United States | $2.204B | 9.40 |
| GeneDx Holdings (WGS) | United States | $1.949B | 75.07 |
| Progyny (PGNY) | United States | $1.912B | 42.08 |
| Premier (PINC) | United States | $1.904B | 14.45 |
| PACS (PACS) | United States | $1.647B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.414B | 28.29 |
| Teladoc Health (TDOC) | United States | $1.319B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.283B | 9.76 |
| Establishment Labs Holdings (ESTA) | $1.046B | 0.00 | |
| Agilon Health (AGL) | United States | $1.014B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.977B | 15.25 |
| Nutex Health (NUTX) | United States | $0.972B | 14.69 |
| AMN Healthcare Services Inc (AMN) | United States | $0.869B | 8.13 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.702B | 4.73 |
| InnovAge Holding (INNV) | United States | $0.566B | 0.00 |
| Enhabit (EHAB) | United States | $0.539B | 44.33 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 13.63 |
| Sonida Senior Living (SNDA) | United States | $0.494B | 0.00 |
| LifeMD (LFMD) | United States | $0.487B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.370B | 0.00 |
| SBC Medicals (SBC) | United States | $0.352B | 0.00 |
| Oncology Institute (TOI) | United States | $0.226B | 0.00 |
| Beauty Health (SKIN) | United States | $0.218B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.209B | 0.00 |
| DocGo (DCGO) | United States | $0.150B | 24.50 |
| Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
| So-Young (SY) | China | $0.084B | 0.00 |
| OncoCyte (OCX) | United States | $0.080B | 0.00 |
| KindlyMD (KDLY) | United States | $0.078B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.044B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.036B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |